Bcel stock forecast.
Nov 6, 2023 · Analyst projections state that BCEL is forecast to be at a low of $1.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -3361.54% from its current level, while the stock would need to crash -284.62% from its current level to reach the projected low. Atreca Inc (BCEL) estimates and forecasts
Atreca Inc (NASDAQ:BCEL) 0.2302. Delayed Data. As of Nov 30. +0.0047 / +2.19%. Today’s Change. 0.19. Today ||| 52-Week Range. 2.05.Over the last year, the company’s stock hit its highest at $2.05 on 01/31/23, while the lowest price during the same time frame was $0.21, recorded on 10/09/23. 52-week price history of BCEL Stock. The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential.Stock Target Advisor’s own stock analysis of Atreca Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Atreca Inc’s stock price was USD 0.22. Atreca Inc’s stock price has changed by -5.11% over the past week, +8.25% over the past month and -79.54% over the last year.2010. 90. John Orwin. https://www.atreca.com. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified ...BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the July 20, 2020 when the stock price was at 15.10$.. In the short term (2weeks), BCEL's stock price should outperform the market by 2.41%.During that period the price should oscillate between -10.29% and +13.88%.. In the medium term (3months), BCEL's stock …
Find real-time ALLK - Allakos Inc stock quotes, company profile, news and forecasts from CNN Business.Dec 1, 2023 · Atreca, Inc. - Hold. Zacks' proprietary data indicates that Atreca, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the BCEL shares relative to the market in ... Dec 1, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for BCEL. The average twelve-month price prediction for Atreca is $10.75 with a high price target of $25.00 and a low price target of $4.00. Learn more on BCEL's analyst rating history.
BCEL Stock 12 Months Forecast $2.00 (790.87% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Atreca in the last 3 months. The average price target …
QFIN Stock 12 Months Forecast. $25.75. (85.12% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Qifu Technology in the last 3 months. The average price target is $25.75 with a high forecast of $27.00 and a low forecast of $24.50. The average price target represents a 85.12% change from the last price of $13.91.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25. Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Learn more about Atreca Inc's (BCEL) stock grades for Momentum, Growth and Estimate Revisions and determine whether this Biotechnology & Medical Research stock meets your investment needs. ... The Biotechnology and Medical Research sub-industry has a positive outlook, a historically defensive sub-industry. Drug sales are …
2010. 90. John Orwin. https://www.atreca.com. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified ...
$0.22 USD +0.01 (2.90%) Updated Nov 27, 2023 11:22 AM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores: F Value | A Growth | C Momentum | C VGM Industry …Find real-time VCEL - Vericel Corp stock quotes, company profile, news and forecasts from CNN Business.The average Adma Biologics stock price prediction forecasts a potential upside of 43.11% from the current ADMA share price of $3.96. What is ADMA's forecast return on equity (ROE) for 2023-2026? (NASDAQ: ADMA) forecast ROE is N/A, which is considered weak.Atreca Inc [BCEL] stock prices are down -14.82% to $0.28 at the moment. ... An investor can expect a potential return of 1060.71% based on the average BCEL price forecast. Analyzing the BCEL fundamentals. In this publicly-traded organization, revenue per employee is $8,556, ...See Atreca, Inc. (BCEL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Keurig Dr Pepper Inc have a median target of 37.00, with a high estimate of 42.00 and a low estimate of 27.00. The ...
Shares of Atreca, Inc. (. BCEL Quick Quote. BCEL - Free Report) have been struggling lately and have lost 20% over the past week. However, a hammer chart pattern was formed in its last trading ...Stock Price Forecast The 31 analysts offering 12-month price forecasts for Li Auto Inc have a median target of 51.71, with a high estimate of 79.79 and a low estimate of 35.71.Zacks Equity Research. April 6, 2023 at 9:55 AM · 3 min read. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer chart pattern was ...NSD:BCEL Detailed Stock Analysis, Stock Price Forecast, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes. About Us ... Based on the Atreca Inc stock forecast from 3 analysts, the average analyst target price for Atreca Inc is USD 1.00 over the next 12 months.5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This suggests a possible upside of 4,474.5% from the stock's current price.In 2021 and 2020, respectively 14 and 13 companies raised sums of $250m or more, whilst in 2019 and 2018, the numbers were 3 and 2. Atreca Inc ( NASDAQ: BCEL) IPOd in June 2019, raising ~$114m at ...Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for Atreca stock is $3.38, which predicts an increase of 1,472.09%. The lowest target is $1.00 and the highest is $10. On average, analysts rate Atreca stock as a hold.
Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median ...
Atreca Inc (NASDAQ:BCEL) 0.2302. Delayed Data. As of Nov 30. +0.0047 / +2.19%. Today’s Change. 0.19. Today ||| 52-Week Range. 2.05.Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $24.40 with a high forecast of $33.00 and a low forecast of $20.00. The average price target represents a 29.93% change from the last price of $18.78. Highest Price Target $33.00. Average Price Target $24.40.Analyst Ratings of ATRECA INC - A(NASDAQ:BCEL) stock. Analyst ratings, forecast, price target, upgrades and ... Analysts have set a mean price target forecast of 3.32. This target is 1406.82 ... seem to be have mildly positive about BCEL. In the previous month the buy percentage consensus was at a similar level. BCEL was analyzed by 13 analysts ...Dec 1, 2023 · 3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price. Nov 27, 2023 · Analyst Forecast. According to 5 analysts, the average rating for BCEL stock is "Hold." The 12-month stock price forecast is $3.38, which is an increase of 1,479.44% from the latest price. Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.Analyst Ratings of ATRECA INC - A(NASDAQ:BCEL) stock. Analyst ratings, forecast, price target, upgrades and ... Analysts have set a mean price target forecast of 3.32. This target is 1406.82 ... seem to be have mildly positive about BCEL. In the previous month the buy percentage consensus was at a similar level. BCEL was analyzed by 13 analysts ...
Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...
Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...
Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for Atreca stock is $3.38, which predicts an increase of 1,472.09%. The lowest target is $1.00 and the highest is $10. On average, analysts rate Atreca stock as a hold.Based on short-term price targets offered by four analysts, the average price target for Atreca, Inc. comes to $5.25. The forecasts range from a low of $1.00 to a high of $10.00. The average price ...Stock Analyst Price Targets - Review. Analysts average stock forecasts to be materialized ratio is 4.17% with an average time for these price targets to be met of 0.17 days. Highest price target for BCEL is 5, Lowest price target is 1, average price target is 3. Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 14 …During trading Thursday, 8 stocks traded to a 52-week high, while 130 stocks bottomed out at new 52-week lows. The S&P 500 is down 1.45% so far today while the Dow is down 1.05%, the Nasdaq is down 2....12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ...Patterson-UTI Energy Inc () Stock Market info Recommendations: Buy or sell Patterson-UTI Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Patterson-UTI Energy share forecasts, stock quote and buy / sell signals below.According to present data Patterson-UTI Energy's PTEN shares and potentially …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Li Auto Inc - ADR share forecasts, stock quote and buy / sell signals below. According to present data Li Auto Inc - ADR's LI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Find the latest W&T Offshore, Inc. (WTI) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Nov 29, 2023 · Qifu Technology (NASDAQ:QFIN) pays an annual dividend of $0.98 per share and currently has a dividend yield of 6.10%. QFIN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 28.16%. This payout ratio is at a healthy, sustainable level, below 75%. How much is Atreca stock worth today? ( NASDAQ: BCEL) Atreca currently has 39,295,661 outstanding shares. With Atreca stock trading at $0.27 per share, the total value of Atreca stock (market capitalization) is $10.41M. Atreca stock was originally listed at a price of $18.05 in Jun 20, 2019.
Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of …Aug 14, 2023 · BCEL Earnings Date and Information. Atreca last posted its quarterly earnings data on May 10th, 2023. The reported ($0.54) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.02. Atreca has generated ($2.18) earnings per share over the last year ( ($2.18) diluted earnings per share). Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | NasdaqThe consensus price target of analysts on Wall Street is $2.00, which implies an increase of 89.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $2.00 respectively. As a result, BCEL is trading at a discount of -809.09% off the target high and -809.09% off the low.Instagram:https://instagram. vwcevalue of 1776 to 1976 quartercheapest stocks with highest dividendssaudi amazon Find the latest Patterson-UTI Energy, Inc. (PTEN) stock quote, history, news and other vital information to help you with your stock trading and investing.About the Atreca Inc – Class A stock forecast. As of 2023 November 08, Wednesday current price of BCEL stock is 0.290$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). lowes home imlithium stock etf Patterson-UTI Energy Inc () Stock Market info Recommendations: Buy or sell Patterson-UTI Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Patterson-UTI Energy share forecasts, stock quote and buy / sell signals below.According to present data Patterson-UTI Energy's PTEN shares and potentially … hedge funds real estate See Atreca, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... The 4 analysts offering 1 year price forecasts for BCEL have a max estimate of — …Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...